Researchers at University College London have identified a specific mechanism by which GLP-1 receptor agonists, the drug ...

People using GLP-1 drugs like Ozempic and Wegovy have reported unusual changes to their feet. While "Ozempic feet" is not ...

Research shows potential positive impacts of weight loss drugs.

For years, GLP-1 drugs like Wegovy and Zepbound have transformed the discussion around obesity — but left millions locked out by high price tags, including Medicare recipients. That changes this week.

A meta-analysis of 10 randomized controlled trials involving more than 23,000 participants, presented at the International ...

Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults ...

Researchers found in a 2024 study that users of the drugs may face elevated risks of anxiety, depression and suicidal tendencies.

Over 4,400 lawsuits target Ozempic and GLP-1 drugs for GI injuries, vision loss, and "Ozempic face." Usage stats, shortages, ...

New research suggests GLP-1 medications like Ozempic and Wegovy may help ease symptoms of binge eating disorder and related eating behaviors.

A new drug could help people taking GLP-1 obesity drugs avoid muscle loss that often accompanies rapid weight loss.

Novo Nordisk ​will launch a more affordable authorised copy of its Ozempic diabetes drug in ‌South Africa later this month, partnering with healthcare company Acino to expand patient access.

With the help of exercise, a better diet, a lot of determination, and a GLP-1 medication, Jeanne Erland lost 164 pounds over ...